Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.12 EUR
597.97 K EUR
82.72 M EUR
51.55 M
About Xtant Medical Holdings, Inc.
Sector
Industry
CEO
Sean E. Browne
Website
Headquarters
Belgrade
Founded
2006
FIGI
BBG00M90C196
Xtant Medical Holdings, Inc. designs, and develops orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoSTX, Certex Spinal Fixation System, Axle Interspinous Fusion System, and Calix. The company was founded in 2006 and is headquartered in Belgrade, MT.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of XMS is 0.44 EUR — it has increased by 0.46% in the past 24 hours. Watch XTANT MEDICAL HOLDINGS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange XTANT MEDICAL HOLDINGS INC stocks are traded under the ticker XMS.
XMS stock hasn't changed in a week, the month change is a 21.67% rise, over the last year XTANT MEDICAL HOLDINGS INC has showed a −59.07% decrease.
We've gathered analysts' opinions on XTANT MEDICAL HOLDINGS INC future price: according to them, XMS price has a max estimate of 2.84 EUR and a min estimate of 1.42 EUR. Watch XMS chart and read a more detailed XTANT MEDICAL HOLDINGS INC stock forecast: see what analysts think of XTANT MEDICAL HOLDINGS INC and suggest that you do with its stocks.
XMS stock is 0.46% volatile and has beta coefficient of 1.76. Track XTANT MEDICAL HOLDINGS INC stock price on the chart and check out the list of the most volatile stocks — is XTANT MEDICAL HOLDINGS INC there?
Today XTANT MEDICAL HOLDINGS INC has the market capitalization of 63.08 M, it has increased by 10.01% over the last week.
Yes, you can track XTANT MEDICAL HOLDINGS INC financials in yearly and quarterly reports right on TradingView.
XTANT MEDICAL HOLDINGS INC is going to release the next earnings report on Mar 11, 2025. Keep track of upcoming events with our Earnings Calendar.
XMS earnings for the last quarter are −0.04 EUR per share, whereas the estimation was −0.02 EUR resulting in a −60.00% surprise. The estimated earnings for the next quarter are −0.01 EUR per share. See more details about XTANT MEDICAL HOLDINGS INC earnings.
XTANT MEDICAL HOLDINGS INC revenue for the last quarter amounts to 25.09 M EUR, despite the estimated figure of 26.31 M EUR. In the next quarter, revenue is expected to reach 30.71 M EUR.
XMS net income for the last quarter is −4.51 M EUR, while the quarter before that showed −3.60 M EUR of net income which accounts for −25.18% change. Track more XTANT MEDICAL HOLDINGS INC financial stats to get the full picture.
No, XMS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jan 11, 2025, the company has 215.00 employees. See our rating of the largest employees — is XTANT MEDICAL HOLDINGS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. XTANT MEDICAL HOLDINGS INC EBITDA is −8.90 M EUR, and current EBITDA margin is −7.65%. See more stats in XTANT MEDICAL HOLDINGS INC financial statements.
Like other stocks, XMS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade XTANT MEDICAL HOLDINGS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So XTANT MEDICAL HOLDINGS INC technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating XTANT MEDICAL HOLDINGS INC stock shows the neutral signal. See more of XTANT MEDICAL HOLDINGS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.